Health and Fitness Health and Fitness
Tue, May 12, 2009
[ Tue, May 12th 2009 ] - Market Wire
Medical Nutrition USA, Inc.: Medical Nutrition US .. 13 Webinar -- "Energizing the Elderly"
[ Tue, May 12th 2009 ] - Market Wire
Transition Therapeutics to Hold Conference Call o .. Financial Results on Wednesday, May 13th, at 4:30
[ Tue, May 12th 2009 ] - Market Wire
Galea Life Sciences, Inc.: Valentino Trubiani Named Director of Galea Life Sciences
[ Tue, May 12th 2009 ] - Market Wire
Cancer Therapeutics : Cancer Therapeutics Signs L .. f Intent to Purchase Stake in NanoTherapies, LLC.
[ Tue, May 12th 2009 ] - Market Wire
FORTIS: Announcement Fortis holding
[ Tue, May 12th 2009 ] - Market Wire
Daxor Corp.: Daxor Corporation Announces First Quarter 2009 Earnings and Payment of a Dividend
[ Tue, May 12th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals .. r 2009 Corporate Highlights and Financial Results
Mon, May 11, 2009
[ Mon, May 11th 2009 ] - Market Wire
IDC reports first quarter 2009 results
[ Mon, May 11th 2009 ] - Market Wire
Angiotech and Boston Scientific welcome journal a .. ant differences between drug-eluting stent brands
[ Mon, May 11th 2009 ] - Market Wire
Given Imaging: Given Imaging to Present at the Eighth Annual JMP Securities Research Conference
Fri, May 8, 2009
[ Fri, May 08th 2009 ] - Market Wire
Cancer Therapeutics, Inc.: Cancer Therapeutics, I .. Launches New Web Site -- www.cancer-therapeutics.
[ Fri, May 08th 2009 ] - Market Wire
Cobalis Corp.: Cobalis Corp. (CLSC) Launches Pate .. evention Product PreHistin(R) for Worldwide Sales
[ Fri, May 08th 2009 ] - Market Wire
Toxin Alert Inc.: Toxin Alert Inc. Announces Private Placement of Shares
[ Fri, May 08th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences Receives FDA Approval for New Heart Valve
[ Fri, May 08th 2009 ] - Market Wire
FORTIS: Fortis holding announces strengthened Cor .. ernance model and composition of Board Committees
[ Fri, May 08th 2009 ] - Market Wire
Medical Facilities Corporation to Host 2009 Annual Meeting of Shareholders
[ Fri, May 08th 2009 ] - Market Wire
DiagnoCure announces completion of investment of US$5 million by Gen&;#8208;Probe Incorporated
[ Fri, May 08th 2009 ] - Market Wire
AMI Research: AMI Research Provides Q1 2009 Stock Valuation Report on NeoGenomics, Inc.
[ Fri, May 08th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio Reports First Quarter 2009 Results
[ Fri, May 08th 2009 ] - Market Wire
Hooper Holmes: Hooper Holmes Announces First Quarter 2009 Results
[ Fri, May 08th 2009 ] - Market Wire
China Aoxing Pharmaceutical Co., Inc.: China Aoxi .. Present at Two Institutional Conferences in the U
Thu, May 7, 2009
[ Thu, May 07th 2009 ] - Market Wire
Facet Biotech Corporation: Facet Biotech Announce .. f America and Merrill Lynch 2009 Health Care Conf
Thu, April 16, 2009
[ Thu, Apr 16th 2009 ] - Market Wire
Pressure BioSciences, Inc.: Pressure BioSciences, .. h Brothers 6th Annual Small Cap Equity Conference
[ Thu, Apr 16th 2009 ] - Market Wire
Paradigm Medical Industries Inc.: Paradigm Medica .. s Signs Worldwide Distribution Agreement With CSO
[ Thu, Apr 16th 2009 ] - Market Wire
SCOLR PHARMA, INC. : SCOLR PHARMA, INC. to Presen .. h Brothers 6th Annual Small Cap Equity Conference
[ Thu, Apr 16th 2009 ] - Market Wire
Marani Spirits: Marani Brands Moves Into New York
[ Thu, Apr 16th 2009 ] - Market Wire
Given Imaging: Given Imaging to Host First Quarter 2009 Financial Results Conference Calls
[ Thu, Apr 16th 2009 ] - Market Wire
Health This Week with Don Baillargeon; Cord Blood .. Medical Association; Health Wellness Studios, In
Wed, April 15, 2009
[ Wed, Apr 15th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE to Transfer to The NASDAQ Capital Market
[ Wed, Apr 15th 2009 ] - Market Wire
The Medicines Company: The Medicines Company to A .. 09 Financial Results on Wednesday, April 29, 2009

The Medicines Company: The Medicines Company to Announce First Quarter 2009 Financial Results on Wednesday, April 29, 2009


Published on 2009-04-15 14:12:27, Last Modified on 2009-04-15 14:12:56 - Market Wire
  Print publication without navigation


PARSIPPANY, NJ--(Marketwire - April 15, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled its quarterly conference call for Wednesday, April 29, 2009 at 8:30 a.m. Eastern Time to discuss first quarter 2009 financial results and operational developments.

The conference call will be available via phone and webcast. The dial in information is listed below: 

 Domestic Dial In: 800-706-7745 International Dial In: 617-614-3472 Passcode for both dial in numbers: 34239136

Replay is available from 11:30 a.m. Eastern Time following the conference call through May 13, 2009. To hear a replay of the call, dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 33236910.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU2010, in early-stage development. Through the acquisition of Targanta Therapeutics, The Medicines Company's pipeline also includes oritavancin, a semi-synthetic lipoglycopeptide antibiotic currently awaiting EU regulatory approval. The Medicines Company's website is [ www.themedicinescompany.com ].

Contributing Sources